Trending Stories on Eyewire+
J&J's Tecnis Odyssey PC-IOL Now Fully Commercially Available
Johnson & Johnson announced the expansion of its Tecnis Odyssey presbyopia-correcting IOL (PC-IOL) across the US. The Tecnis Odyssey IOL offers patients continuous full-range vision, reducing the need for glasses by providing... Read More
Zeiss Launches Micor 700 Lens Extraction Device
Zeiss?announced the US?launch of the Micor?700 lens extraction device, which is designed to eliminate?the need for ultrasound, offering a more sustainable and cost-effective solution while expanding the... Read More
Eyenovia Launches Clobetasol for Postoperative Ocular Surgery Pain and Inflammation
Eyenovia announced the US?launch and commercial availability of clobetasol propionate ophthalmic suspension 0.05%, which is designed to address postoperative inflammation and pain following ocular surgeries. The FDA approval and?launch marks?the first new ophthalmic steroid to be...Read More
EyewireTV | 09.24.2024
Two collaborations are made to develop and market new glaucoma treatments; Apellis receives feedback from a committee of thee EMA for its geographic atrophy treatment?pegcetacoplan; and Topcon receives FDA clearance for OCTA on the company’s Maestro2 fundus camera system.?Click here to check it out!
Latest In Podcasts
领英推荐
Transforming Global Eye Care
Neda Nikpoor, MD, and Neda Shamie, MD, interview Geoffrey Tabin, MD, cofounder of Cure Blindness Project and a Professor of Ophthalmology and Global Medicine at Stanford University. Dr. Tabin shares his inspiring journey from witnessing the transformative impact of cataract surgery in Nepal to dedicating his life to combating preventable blindness worldwide. Catch the latest episode here!
Case Review: Elevated IOP and Disc Thinning
Sila Bal, MD, MPH, invites Rachel Simpson, MD, to review a case of a 56-year-old woman who presented with elevated intraocular pressure with inferior and superior disc thinning. The patient had not undergone an eye examination in 10 years and experienced no other visual symptoms. Catch the latest episode here!
Eyewire News: The Podcast
Two collaborations are made to develop and market new glaucoma treatments; Apellis receives feedback from a committee of thee EMA for its geographic atrophy treatment pegcetacoplan; and Topcon receives FDA clearance for OCTA on the company’s Maestro2 fundus camera system. Catch the latest episodes here!
Latest in Subspecialties:
Thank you for reading! We'll be back next week with another edition of?Eyewire+ Weekly Digest. For the most up to date news, please visit us at Eyewire+.